Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-02 20:28:50 - browse：997

Adobe

WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： FDA panel to weigh safety of artificial wombs for preterm births

WSS

Why the quest to eradicate polio has stumbled

Cancer, immunology, HIV research ensnared in fetal tissue politics

Pregnancy ages women, but effects reverse after delivery

How the messy conversation about Dolly changed bioethics

CRISPR technology availability, affordability needs to be expanded

Medicare Advantage insurers pressure Biden for bigger payments

Wikipedia

Wikipedia

focus

New air purifier tech could be key to improving indoor air quality

'Patient friction coefficient' can gauge a clinical trial's patient burden

23andMe had bad news about my health. I wish a person had delivered it

With Wegovy coverage, Medicare patients may face high costs

Anesthesiologist group: stop taking Ozempic before surgery

Patients, doctors press FTC to beef up hospital merger scrutiny

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA panel to weigh safety of artificial wombs for preterm births

Affirmative action in medical school literally saved lives

U.K. officials, researchers try to ease path for bespoke genetic treatments

knowledge

Mirador, a new biotech startup, launches with $400 million

Neurocrine congenital adrenal hyperplasia trial succeeds

This gene therapy has record $4.25 million price. It's saved children.

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Mirador, a new biotech startup, launches with $400 million

PBMs drew scrutiny in House hearing — and so did pharma

focus

focus

focus

leisure time